Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02057731 · ClinicalTrials.gov registry record
Study of Glycogen Storage Disease Expression in Carriers
A clinical trial of Glycogen Storage Disease, sponsored by University of Florida.
- Completed
- Registry status
- 114
- Enrollment target
- 1
- Study location
NCT02057731 is a study of Glycogen Storage Disease that has completed, run by University of Florida. The registered enrollment target is 114 participants, above the 72-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02057731, a study of Glycogen Storage Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether carrier status for any type of glycogen storage disease (GSD) predisposes the carrier to GSD markers, like high cholesterol, by testing blood, urine, and saliva samples.
Conditions Studied
Interventions
- GENETIC Glycogen Storage Disease markers
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02057731
The ClinicalTrials.gov registry entry for NCT02057731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (58% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glycogen Storage Disease appearing as the primary indexed condition, and to 1 intervention - of which Glycogen Storage Disease markers is the first listed.
NCT02057731 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02057731 about?
NCT02057731 is a clinical study titled "Study of Glycogen Storage Disease Expression in Carriers". The purpose of the study is to determine whether carrier status for any type of glycogen storage disease (GSD) predisposes the carrier to GSD markers, like high cholesterol, by testing blood, urine, and saliva samples.
What is the current status of trial NCT02057731?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2014-02. Estimated completion is 2016-07.
What conditions does trial NCT02057731 study?
This clinical trial studies the following conditions: Glycogen Storage Disease.
What interventions are being tested in trial NCT02057731?
The interventions under investigation include: Glycogen Storage Disease markers (GENETIC).
Who is sponsoring clinical trial NCT02057731?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02057731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.